Global mRNA Therapy Market Research Report 2026(Status and Outlook)
By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global mRNA Therapy market size was estimated at USD 44900.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global mRNA Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global mRNA Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the mRNA Therapy market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of mRNA Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global mRNA Therapy market size was estimated at USD 44900.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global mRNA Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global mRNA Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the mRNA Therapy market.
Global mRNA Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Moderna
- BioNTech
- Pfizer
- Arcturus Therapeutics Holdings Inc.
- Astrazeneca
- CureVac
- Translate Bio
- Regeneron Pharmaceuticals
- Arcturus Therapeutics
- Takeda Pharmaceutical Company
- Novartis
- Sanofi
Market Segmentation (by Type)
- Vaccine
- Drugs
Market Segmentation (by Application)
- mRNA Targeted Delivery in vivo
- Genetically Modified T cells
- Transforming Nanoparticles to Develop Immunotherapy for Cancer
- Small Molecule Drugs Discovery
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the mRNA Therapy Market
Overview of the regional outlook of the mRNA Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of mRNA Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of mRNA Therapy
1.2 Key Market Segments
1.2.1 mRNA Therapy Segment by Type
1.2.2 mRNA Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global mRNA Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global mRNA Therapy Product Life Cycle
3.3 Global mRNA Therapy Sales by Manufacturers (2020-2025)
3.4 Global mRNA Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global mRNA Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 mRNA Therapy Market Competitive Situation and Trends
3.8.1 mRNA Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest mRNA Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MRNA THERAPY INDUSTRY CHAIN ANALYSIS
4.1 mRNA Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global mRNA Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to mRNA Therapy Market
5.7 ESG Ratings of Leading Companies
6 MRNA THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Therapy Sales Market Share by Type (2020-2025)
6.3 Global mRNA Therapy Market Size by Type (2020-2025)
6.4 Global mRNA Therapy Price by Type (2020-2025)
7 MRNA THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Therapy Market Sales by Application (2020-2025)
7.3 Global mRNA Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global mRNA Therapy Sales Growth Rate by Application (2020-2025)
8 MRNA THERAPY MARKET SALES BY REGION
8.1 Global mRNA Therapy Sales by Region
8.1.1 Global mRNA Therapy Sales by Region
8.1.2 Global mRNA Therapy Sales Market Share by Region
8.2 Global mRNA Therapy Market Size by Region
8.2.1 Global mRNA Therapy Market Size by Region
8.2.2 Global mRNA Therapy Market Size by Region
8.3 North America
8.3.1 North America mRNA Therapy Sales by Country
8.3.2 North America mRNA Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe mRNA Therapy Sales by Country
8.4.2 Europe mRNA Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific mRNA Therapy Sales by Region
8.5.2 Asia Pacific mRNA Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America mRNA Therapy Sales by Country
8.6.2 South America mRNA Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa mRNA Therapy Sales by Region
8.7.2 Middle East and Africa mRNA Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MRNA THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of mRNA Therapy by Region(2020-2025)
9.2 Global mRNA Therapy Revenue Market Share by Region (2020-2025)
9.3 Global mRNA Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America mRNA Therapy Production
9.4.1 North America mRNA Therapy Production Growth Rate (2020-2025)
9.4.2 North America mRNA Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe mRNA Therapy Production
9.5.1 Europe mRNA Therapy Production Growth Rate (2020-2025)
9.5.2 Europe mRNA Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan mRNA Therapy Production (2020-2025)
9.6.1 Japan mRNA Therapy Production Growth Rate (2020-2025)
9.6.2 Japan mRNA Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China mRNA Therapy Production (2020-2025)
9.7.1 China mRNA Therapy Production Growth Rate (2020-2025)
9.7.2 China mRNA Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Moderna
10.1.1 Moderna Basic Information
10.1.2 Moderna mRNA Therapy Product Overview
10.1.3 Moderna mRNA Therapy Product Market Performance
10.1.4 Moderna Business Overview
10.1.5 Moderna SWOT Analysis
10.1.6 Moderna Recent Developments
10.2 BioNTech
10.2.1 BioNTech Basic Information
10.2.2 BioNTech mRNA Therapy Product Overview
10.2.3 BioNTech mRNA Therapy Product Market Performance
10.2.4 BioNTech Business Overview
10.2.5 BioNTech SWOT Analysis
10.2.6 BioNTech Recent Developments
10.3 Pfizer
10.3.1 Pfizer Basic Information
10.3.2 Pfizer mRNA Therapy Product Overview
10.3.3 Pfizer mRNA Therapy Product Market Performance
10.3.4 Pfizer Business Overview
10.3.5 Pfizer SWOT Analysis
10.3.6 Pfizer Recent Developments
10.4 Arcturus Therapeutics Holdings Inc.
10.4.1 Arcturus Therapeutics Holdings Inc. Basic Information
10.4.2 Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Overview
10.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Market Performance
10.4.4 Arcturus Therapeutics Holdings Inc. Business Overview
10.4.5 Arcturus Therapeutics Holdings Inc. Recent Developments
10.5 Astrazeneca
10.5.1 Astrazeneca Basic Information
10.5.2 Astrazeneca mRNA Therapy Product Overview
10.5.3 Astrazeneca mRNA Therapy Product Market Performance
10.5.4 Astrazeneca Business Overview
10.5.5 Astrazeneca Recent Developments
10.6 CureVac
10.6.1 CureVac Basic Information
10.6.2 CureVac mRNA Therapy Product Overview
10.6.3 CureVac mRNA Therapy Product Market Performance
10.6.4 CureVac Business Overview
10.6.5 CureVac Recent Developments
10.7 Translate Bio
10.7.1 Translate Bio Basic Information
10.7.2 Translate Bio mRNA Therapy Product Overview
10.7.3 Translate Bio mRNA Therapy Product Market Performance
10.7.4 Translate Bio Business Overview
10.7.5 Translate Bio Recent Developments
10.8 Regeneron Pharmaceuticals
10.8.1 Regeneron Pharmaceuticals Basic Information
10.8.2 Regeneron Pharmaceuticals mRNA Therapy Product Overview
10.8.3 Regeneron Pharmaceuticals mRNA Therapy Product Market Performance
10.8.4 Regeneron Pharmaceuticals Business Overview
10.8.5 Regeneron Pharmaceuticals Recent Developments
10.9 Arcturus Therapeutics
10.9.1 Arcturus Therapeutics Basic Information
10.9.2 Arcturus Therapeutics mRNA Therapy Product Overview
10.9.3 Arcturus Therapeutics mRNA Therapy Product Market Performance
10.9.4 Arcturus Therapeutics Business Overview
10.9.5 Arcturus Therapeutics Recent Developments
10.10 Takeda Pharmaceutical Company
10.10.1 Takeda Pharmaceutical Company Basic Information
10.10.2 Takeda Pharmaceutical Company mRNA Therapy Product Overview
10.10.3 Takeda Pharmaceutical Company mRNA Therapy Product Market Performance
10.10.4 Takeda Pharmaceutical Company Business Overview
10.10.5 Takeda Pharmaceutical Company Recent Developments
10.11 Novartis
10.11.1 Novartis Basic Information
10.11.2 Novartis mRNA Therapy Product Overview
10.11.3 Novartis mRNA Therapy Product Market Performance
10.11.4 Novartis Business Overview
10.11.5 Novartis Recent Developments
10.12 Sanofi
10.12.1 Sanofi Basic Information
10.12.2 Sanofi mRNA Therapy Product Overview
10.12.3 Sanofi mRNA Therapy Product Market Performance
10.12.4 Sanofi Business Overview
10.12.5 Sanofi Recent Developments
11 MRNA THERAPY MARKET FORECAST BY REGION
11.1 Global mRNA Therapy Market Size Forecast
11.2 Global mRNA Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe mRNA Therapy Market Size Forecast by Country
11.2.3 Asia Pacific mRNA Therapy Market Size Forecast by Region
11.2.4 South America mRNA Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of mRNA Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global mRNA Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of mRNA Therapy by Type (2026-2035)
12.1.2 Global mRNA Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of mRNA Therapy by Type (2026-2035)
12.2 Global mRNA Therapy Market Forecast by Application (2026-2035)
12.2.1 Global mRNA Therapy Sales (K Units) Forecast by Application
12.2.2 Global mRNA Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of mRNA Therapy
1.2 Key Market Segments
1.2.1 mRNA Therapy Segment by Type
1.2.2 mRNA Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRNA THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global mRNA Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global mRNA Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRNA THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global mRNA Therapy Product Life Cycle
3.3 Global mRNA Therapy Sales by Manufacturers (2020-2025)
3.4 Global mRNA Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global mRNA Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 mRNA Therapy Market Competitive Situation and Trends
3.8.1 mRNA Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest mRNA Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MRNA THERAPY INDUSTRY CHAIN ANALYSIS
4.1 mRNA Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRNA THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global mRNA Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to mRNA Therapy Market
5.7 ESG Ratings of Leading Companies
6 MRNA THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Therapy Sales Market Share by Type (2020-2025)
6.3 Global mRNA Therapy Market Size by Type (2020-2025)
6.4 Global mRNA Therapy Price by Type (2020-2025)
7 MRNA THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Therapy Market Sales by Application (2020-2025)
7.3 Global mRNA Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global mRNA Therapy Sales Growth Rate by Application (2020-2025)
8 MRNA THERAPY MARKET SALES BY REGION
8.1 Global mRNA Therapy Sales by Region
8.1.1 Global mRNA Therapy Sales by Region
8.1.2 Global mRNA Therapy Sales Market Share by Region
8.2 Global mRNA Therapy Market Size by Region
8.2.1 Global mRNA Therapy Market Size by Region
8.2.2 Global mRNA Therapy Market Size by Region
8.3 North America
8.3.1 North America mRNA Therapy Sales by Country
8.3.2 North America mRNA Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe mRNA Therapy Sales by Country
8.4.2 Europe mRNA Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific mRNA Therapy Sales by Region
8.5.2 Asia Pacific mRNA Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America mRNA Therapy Sales by Country
8.6.2 South America mRNA Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa mRNA Therapy Sales by Region
8.7.2 Middle East and Africa mRNA Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MRNA THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of mRNA Therapy by Region(2020-2025)
9.2 Global mRNA Therapy Revenue Market Share by Region (2020-2025)
9.3 Global mRNA Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America mRNA Therapy Production
9.4.1 North America mRNA Therapy Production Growth Rate (2020-2025)
9.4.2 North America mRNA Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe mRNA Therapy Production
9.5.1 Europe mRNA Therapy Production Growth Rate (2020-2025)
9.5.2 Europe mRNA Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan mRNA Therapy Production (2020-2025)
9.6.1 Japan mRNA Therapy Production Growth Rate (2020-2025)
9.6.2 Japan mRNA Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China mRNA Therapy Production (2020-2025)
9.7.1 China mRNA Therapy Production Growth Rate (2020-2025)
9.7.2 China mRNA Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Moderna
10.1.1 Moderna Basic Information
10.1.2 Moderna mRNA Therapy Product Overview
10.1.3 Moderna mRNA Therapy Product Market Performance
10.1.4 Moderna Business Overview
10.1.5 Moderna SWOT Analysis
10.1.6 Moderna Recent Developments
10.2 BioNTech
10.2.1 BioNTech Basic Information
10.2.2 BioNTech mRNA Therapy Product Overview
10.2.3 BioNTech mRNA Therapy Product Market Performance
10.2.4 BioNTech Business Overview
10.2.5 BioNTech SWOT Analysis
10.2.6 BioNTech Recent Developments
10.3 Pfizer
10.3.1 Pfizer Basic Information
10.3.2 Pfizer mRNA Therapy Product Overview
10.3.3 Pfizer mRNA Therapy Product Market Performance
10.3.4 Pfizer Business Overview
10.3.5 Pfizer SWOT Analysis
10.3.6 Pfizer Recent Developments
10.4 Arcturus Therapeutics Holdings Inc.
10.4.1 Arcturus Therapeutics Holdings Inc. Basic Information
10.4.2 Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Overview
10.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Market Performance
10.4.4 Arcturus Therapeutics Holdings Inc. Business Overview
10.4.5 Arcturus Therapeutics Holdings Inc. Recent Developments
10.5 Astrazeneca
10.5.1 Astrazeneca Basic Information
10.5.2 Astrazeneca mRNA Therapy Product Overview
10.5.3 Astrazeneca mRNA Therapy Product Market Performance
10.5.4 Astrazeneca Business Overview
10.5.5 Astrazeneca Recent Developments
10.6 CureVac
10.6.1 CureVac Basic Information
10.6.2 CureVac mRNA Therapy Product Overview
10.6.3 CureVac mRNA Therapy Product Market Performance
10.6.4 CureVac Business Overview
10.6.5 CureVac Recent Developments
10.7 Translate Bio
10.7.1 Translate Bio Basic Information
10.7.2 Translate Bio mRNA Therapy Product Overview
10.7.3 Translate Bio mRNA Therapy Product Market Performance
10.7.4 Translate Bio Business Overview
10.7.5 Translate Bio Recent Developments
10.8 Regeneron Pharmaceuticals
10.8.1 Regeneron Pharmaceuticals Basic Information
10.8.2 Regeneron Pharmaceuticals mRNA Therapy Product Overview
10.8.3 Regeneron Pharmaceuticals mRNA Therapy Product Market Performance
10.8.4 Regeneron Pharmaceuticals Business Overview
10.8.5 Regeneron Pharmaceuticals Recent Developments
10.9 Arcturus Therapeutics
10.9.1 Arcturus Therapeutics Basic Information
10.9.2 Arcturus Therapeutics mRNA Therapy Product Overview
10.9.3 Arcturus Therapeutics mRNA Therapy Product Market Performance
10.9.4 Arcturus Therapeutics Business Overview
10.9.5 Arcturus Therapeutics Recent Developments
10.10 Takeda Pharmaceutical Company
10.10.1 Takeda Pharmaceutical Company Basic Information
10.10.2 Takeda Pharmaceutical Company mRNA Therapy Product Overview
10.10.3 Takeda Pharmaceutical Company mRNA Therapy Product Market Performance
10.10.4 Takeda Pharmaceutical Company Business Overview
10.10.5 Takeda Pharmaceutical Company Recent Developments
10.11 Novartis
10.11.1 Novartis Basic Information
10.11.2 Novartis mRNA Therapy Product Overview
10.11.3 Novartis mRNA Therapy Product Market Performance
10.11.4 Novartis Business Overview
10.11.5 Novartis Recent Developments
10.12 Sanofi
10.12.1 Sanofi Basic Information
10.12.2 Sanofi mRNA Therapy Product Overview
10.12.3 Sanofi mRNA Therapy Product Market Performance
10.12.4 Sanofi Business Overview
10.12.5 Sanofi Recent Developments
11 MRNA THERAPY MARKET FORECAST BY REGION
11.1 Global mRNA Therapy Market Size Forecast
11.2 Global mRNA Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe mRNA Therapy Market Size Forecast by Country
11.2.3 Asia Pacific mRNA Therapy Market Size Forecast by Region
11.2.4 South America mRNA Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of mRNA Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global mRNA Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of mRNA Therapy by Type (2026-2035)
12.1.2 Global mRNA Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of mRNA Therapy by Type (2026-2035)
12.2 Global mRNA Therapy Market Forecast by Application (2026-2035)
12.2.1 Global mRNA Therapy Sales (K Units) Forecast by Application
12.2.2 Global mRNA Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global mRNA Therapy Market Size by Type (M USD)
Table 4. Global mRNA Therapy Market Size by Application
Table 5. mRNA Therapy Market Size Comparison by Region (M USD)
Table 6. Global mRNA Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global mRNA Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global mRNA Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global mRNA Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Therapy as of 2025)
Table 11. Global Market mRNA Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global mRNA Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global mRNA Therapy Sales by Type (K Units)
Table 27. Global mRNA Therapy Market Size by Type (M USD)
Table 28. Global mRNA Therapy Sales (K Units) by Type (2020-2025)
Table 29. Global mRNA Therapy Sales Market Share by Type (2020-2025)
Table 30. Global mRNA Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global mRNA Therapy Market Share by Type (2020-2025)
Table 32. Global mRNA Therapy Price (USD/Unit) by Type (2020-2025)
Table 33. Global mRNA Therapy Sales (K Units) by Application
Table 34. Global mRNA Therapy Market Size by Application
Table 35. Global mRNA Therapy Sales by Application (2020-2025) & (K Units)
Table 36. Global mRNA Therapy Sales Market Share by Application (2020-2025)
Table 37. Global mRNA Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global mRNA Therapy Market Share by Application (2020-2025)
Table 39. Global mRNA Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global mRNA Therapy Sales by Region (2020-2025) & (K Units)
Table 41. Global mRNA Therapy Sales Market Share by Region (2020-2025)
Table 42. Global mRNA Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global mRNA Therapy Market Size by Region (2020-2025)
Table 44. North America mRNA Therapy Sales by Country (2020-2025) & (K Units)
Table 45. North America mRNA Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe mRNA Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Europe mRNA Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific mRNA Therapy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific mRNA Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America mRNA Therapy Sales by Country (2020-2025) & (K Units)
Table 51. South America mRNA Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa mRNA Therapy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa mRNA Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global mRNA Therapy Production (K Units) by Region(2020-2025)
Table 55. Global mRNA Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global mRNA Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Moderna Basic Information
Table 63. Moderna mRNA Therapy Product Overview
Table 64. Moderna mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Moderna Business Overview
Table 66. Moderna SWOT Analysis
Table 67. Moderna Recent Developments
Table 68. BioNTech Basic Information
Table 69. BioNTech mRNA Therapy Product Overview
Table 70. BioNTech mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. BioNTech Business Overview
Table 72. BioNTech SWOT Analysis
Table 73. BioNTech Recent Developments
Table 74. Pfizer Basic Information
Table 75. Pfizer mRNA Therapy Product Overview
Table 76. Pfizer mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Pfizer Business Overview
Table 78. Pfizer SWOT Analysis
Table 79. Pfizer Recent Developments
Table 80. Arcturus Therapeutics Holdings Inc. Basic Information
Table 81. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Overview
Table 82. Arcturus Therapeutics Holdings Inc. mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Arcturus Therapeutics Holdings Inc. Business Overview
Table 84. Arcturus Therapeutics Holdings Inc. Recent Developments
Table 85. Astrazeneca Basic Information
Table 86. Astrazeneca mRNA Therapy Product Overview
Table 87. Astrazeneca mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Astrazeneca Business Overview
Table 89. Astrazeneca Recent Developments
Table 90. CureVac Basic Information
Table 91. CureVac mRNA Therapy Product Overview
Table 92. CureVac mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. CureVac Business Overview
Table 94. CureVac Recent Developments
Table 95. Translate Bio Basic Information
Table 96. Translate Bio mRNA Therapy Product Overview
Table 97. Translate Bio mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Translate Bio Business Overview
Table 99. Translate Bio Recent Developments
Table 100. Regeneron Pharmaceuticals Basic Information
Table 101. Regeneron Pharmaceuticals mRNA Therapy Product Overview
Table 102. Regeneron Pharmaceuticals mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Regeneron Pharmaceuticals Business Overview
Table 104. Regeneron Pharmaceuticals Recent Developments
Table 105. Arcturus Therapeutics Basic Information
Table 106. Arcturus Therapeutics mRNA Therapy Product Overview
Table 107. Arcturus Therapeutics mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Arcturus Therapeutics Business Overview
Table 109. Arcturus Therapeutics Recent Developments
Table 110. Takeda Pharmaceutical Company Basic Information
Table 111. Takeda Pharmaceutical Company mRNA Therapy Product Overview
Table 112. Takeda Pharmaceutical Company mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Takeda Pharmaceutical Company Business Overview
Table 114. Takeda Pharmaceutical Company Recent Developments
Table 115. Novartis Basic Information
Table 116. Novartis mRNA Therapy Product Overview
Table 117. Novartis mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Novartis Business Overview
Table 119. Novartis Recent Developments
Table 120. Sanofi Basic Information
Table 121. Sanofi mRNA Therapy Product Overview
Table 122. Sanofi mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Sanofi Business Overview
Table 124. Sanofi Recent Developments
Table 125. Global mRNA Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global mRNA Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America mRNA Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America mRNA Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe mRNA Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe mRNA Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific mRNA Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific mRNA Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America mRNA Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America mRNA Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa mRNA Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa mRNA Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global mRNA Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global mRNA Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global mRNA Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global mRNA Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global mRNA Therapy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global mRNA Therapy Market Size by Type (M USD)
Table 4. Global mRNA Therapy Market Size by Application
Table 5. mRNA Therapy Market Size Comparison by Region (M USD)
Table 6. Global mRNA Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global mRNA Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global mRNA Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global mRNA Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Therapy as of 2025)
Table 11. Global Market mRNA Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global mRNA Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global mRNA Therapy Sales by Type (K Units)
Table 27. Global mRNA Therapy Market Size by Type (M USD)
Table 28. Global mRNA Therapy Sales (K Units) by Type (2020-2025)
Table 29. Global mRNA Therapy Sales Market Share by Type (2020-2025)
Table 30. Global mRNA Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global mRNA Therapy Market Share by Type (2020-2025)
Table 32. Global mRNA Therapy Price (USD/Unit) by Type (2020-2025)
Table 33. Global mRNA Therapy Sales (K Units) by Application
Table 34. Global mRNA Therapy Market Size by Application
Table 35. Global mRNA Therapy Sales by Application (2020-2025) & (K Units)
Table 36. Global mRNA Therapy Sales Market Share by Application (2020-2025)
Table 37. Global mRNA Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global mRNA Therapy Market Share by Application (2020-2025)
Table 39. Global mRNA Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global mRNA Therapy Sales by Region (2020-2025) & (K Units)
Table 41. Global mRNA Therapy Sales Market Share by Region (2020-2025)
Table 42. Global mRNA Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global mRNA Therapy Market Size by Region (2020-2025)
Table 44. North America mRNA Therapy Sales by Country (2020-2025) & (K Units)
Table 45. North America mRNA Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe mRNA Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Europe mRNA Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific mRNA Therapy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific mRNA Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America mRNA Therapy Sales by Country (2020-2025) & (K Units)
Table 51. South America mRNA Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa mRNA Therapy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa mRNA Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global mRNA Therapy Production (K Units) by Region(2020-2025)
Table 55. Global mRNA Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global mRNA Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China mRNA Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Moderna Basic Information
Table 63. Moderna mRNA Therapy Product Overview
Table 64. Moderna mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Moderna Business Overview
Table 66. Moderna SWOT Analysis
Table 67. Moderna Recent Developments
Table 68. BioNTech Basic Information
Table 69. BioNTech mRNA Therapy Product Overview
Table 70. BioNTech mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. BioNTech Business Overview
Table 72. BioNTech SWOT Analysis
Table 73. BioNTech Recent Developments
Table 74. Pfizer Basic Information
Table 75. Pfizer mRNA Therapy Product Overview
Table 76. Pfizer mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Pfizer Business Overview
Table 78. Pfizer SWOT Analysis
Table 79. Pfizer Recent Developments
Table 80. Arcturus Therapeutics Holdings Inc. Basic Information
Table 81. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Overview
Table 82. Arcturus Therapeutics Holdings Inc. mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Arcturus Therapeutics Holdings Inc. Business Overview
Table 84. Arcturus Therapeutics Holdings Inc. Recent Developments
Table 85. Astrazeneca Basic Information
Table 86. Astrazeneca mRNA Therapy Product Overview
Table 87. Astrazeneca mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Astrazeneca Business Overview
Table 89. Astrazeneca Recent Developments
Table 90. CureVac Basic Information
Table 91. CureVac mRNA Therapy Product Overview
Table 92. CureVac mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. CureVac Business Overview
Table 94. CureVac Recent Developments
Table 95. Translate Bio Basic Information
Table 96. Translate Bio mRNA Therapy Product Overview
Table 97. Translate Bio mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Translate Bio Business Overview
Table 99. Translate Bio Recent Developments
Table 100. Regeneron Pharmaceuticals Basic Information
Table 101. Regeneron Pharmaceuticals mRNA Therapy Product Overview
Table 102. Regeneron Pharmaceuticals mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Regeneron Pharmaceuticals Business Overview
Table 104. Regeneron Pharmaceuticals Recent Developments
Table 105. Arcturus Therapeutics Basic Information
Table 106. Arcturus Therapeutics mRNA Therapy Product Overview
Table 107. Arcturus Therapeutics mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Arcturus Therapeutics Business Overview
Table 109. Arcturus Therapeutics Recent Developments
Table 110. Takeda Pharmaceutical Company Basic Information
Table 111. Takeda Pharmaceutical Company mRNA Therapy Product Overview
Table 112. Takeda Pharmaceutical Company mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Takeda Pharmaceutical Company Business Overview
Table 114. Takeda Pharmaceutical Company Recent Developments
Table 115. Novartis Basic Information
Table 116. Novartis mRNA Therapy Product Overview
Table 117. Novartis mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Novartis Business Overview
Table 119. Novartis Recent Developments
Table 120. Sanofi Basic Information
Table 121. Sanofi mRNA Therapy Product Overview
Table 122. Sanofi mRNA Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Sanofi Business Overview
Table 124. Sanofi Recent Developments
Table 125. Global mRNA Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global mRNA Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America mRNA Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America mRNA Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe mRNA Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe mRNA Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific mRNA Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific mRNA Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America mRNA Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America mRNA Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa mRNA Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa mRNA Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global mRNA Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global mRNA Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global mRNA Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global mRNA Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global mRNA Therapy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of mRNA Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Therapy Market Size (M USD), 2025-2035
Figure 5. Global mRNA Therapy Market Size (M USD) (2020-2035)
Figure 6. Global mRNA Therapy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global mRNA Therapy Product Life Cycle
Figure 13. mRNA Therapy Sales Share by Manufacturers in 2025
Figure 14. Global mRNA Therapy Revenue Share by Manufacturers in 2025
Figure 15. mRNA Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market mRNA Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by mRNA Therapy Revenue in 2025
Figure 18. Industry Chain Map of mRNA Therapy
Figure 19. Global mRNA Therapy Market PEST Analysis
Figure 20. Global mRNA Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global mRNA Therapy Market Share by Type
Figure 27. Sales Market Share of mRNA Therapy by Type (2020-2025)
Figure 28. Sales Market Share of mRNA Therapy by Type in 2025
Figure 29. Market Share of mRNA Therapy by Type (2020-2025)
Figure 30. Market Share of mRNA Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global mRNA Therapy Market Share by Application
Figure 33. Global mRNA Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global mRNA Therapy Sales Market Share by Application in 2025
Figure 35. Global mRNA Therapy Market Share by Application (2020-2025)
Figure 36. Global mRNA Therapy Market Share by Application in 2025
Figure 37. Global mRNA Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global mRNA Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global mRNA Therapy Market Size by Region (2020-2025)
Figure 40. North America mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America mRNA Therapy Sales Market Share by Country in 2024
Figure 43. North America mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America mRNA Therapy Market Size by Country in 2024
Figure 45. U.S. mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada mRNA Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada mRNA Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico mRNA Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico mRNA Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe mRNA Therapy Sales Market Share by Country in 2024
Figure 53. Europe mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe mRNA Therapy Market Size by Country in 2024
Figure 55. Germany mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific mRNA Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific mRNA Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific mRNA Therapy Market Size by Region in 2024
Figure 68. China mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America mRNA Therapy Sales and Growth Rate (K Units)
Figure 79. South America mRNA Therapy Sales Market Share by Country in 2024
Figure 80. South America mRNA Therapy Market Size and Growth Rate (M USD)
Figure 81. South America mRNA Therapy Market Size by Country in 2024
Figure 82. Brazil mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa mRNA Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa mRNA Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa mRNA Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa mRNA Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global mRNA Therapy Production Market Share by Region (2020-2025)
Figure 103. North America mRNA Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe mRNA Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan mRNA Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China mRNA Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global mRNA Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global mRNA Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global mRNA Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global mRNA Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global mRNA Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global mRNA Therapy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of mRNA Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Therapy Market Size (M USD), 2025-2035
Figure 5. Global mRNA Therapy Market Size (M USD) (2020-2035)
Figure 6. Global mRNA Therapy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global mRNA Therapy Product Life Cycle
Figure 13. mRNA Therapy Sales Share by Manufacturers in 2025
Figure 14. Global mRNA Therapy Revenue Share by Manufacturers in 2025
Figure 15. mRNA Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market mRNA Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by mRNA Therapy Revenue in 2025
Figure 18. Industry Chain Map of mRNA Therapy
Figure 19. Global mRNA Therapy Market PEST Analysis
Figure 20. Global mRNA Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global mRNA Therapy Market Share by Type
Figure 27. Sales Market Share of mRNA Therapy by Type (2020-2025)
Figure 28. Sales Market Share of mRNA Therapy by Type in 2025
Figure 29. Market Share of mRNA Therapy by Type (2020-2025)
Figure 30. Market Share of mRNA Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global mRNA Therapy Market Share by Application
Figure 33. Global mRNA Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global mRNA Therapy Sales Market Share by Application in 2025
Figure 35. Global mRNA Therapy Market Share by Application (2020-2025)
Figure 36. Global mRNA Therapy Market Share by Application in 2025
Figure 37. Global mRNA Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global mRNA Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global mRNA Therapy Market Size by Region (2020-2025)
Figure 40. North America mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America mRNA Therapy Sales Market Share by Country in 2024
Figure 43. North America mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America mRNA Therapy Market Size by Country in 2024
Figure 45. U.S. mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada mRNA Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada mRNA Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico mRNA Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico mRNA Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe mRNA Therapy Sales Market Share by Country in 2024
Figure 53. Europe mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe mRNA Therapy Market Size by Country in 2024
Figure 55. Germany mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific mRNA Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific mRNA Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific mRNA Therapy Market Size by Region in 2024
Figure 68. China mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America mRNA Therapy Sales and Growth Rate (K Units)
Figure 79. South America mRNA Therapy Sales Market Share by Country in 2024
Figure 80. South America mRNA Therapy Market Size and Growth Rate (M USD)
Figure 81. South America mRNA Therapy Market Size by Country in 2024
Figure 82. Brazil mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa mRNA Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa mRNA Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa mRNA Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa mRNA Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa mRNA Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa mRNA Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global mRNA Therapy Production Market Share by Region (2020-2025)
Figure 103. North America mRNA Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe mRNA Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan mRNA Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China mRNA Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global mRNA Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global mRNA Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global mRNA Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global mRNA Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global mRNA Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global mRNA Therapy Market Share Forecast by Application (2026-2035)
